Analysis of Virological Efficacy in Trials of Antiretroviral Regimens: Drawbacks of Not Including Viral Load Measurements after Premature Discontinuation of Therapy
Ole Kirk(University of Copenhagen), Jens Lundgren(Centre of Excellence for Health, Immunity and Infections), Joan Montaner(Universitat Autònoma de Barcelona), Graeme Moyle(Chelsea and Westminster Hospital), Roy M. Gulick(New York University), Matthew Law(UNSW Sydney), Andrew Phillips(Wake Forest University), Court Pedersen(Office of Infectious Diseases), Joseph J. Eron(University of North Carolina at Chapel Hill)
Cited by 22
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k
Clinical Characteristics of Covid-19 in New York City
|New England Journal of Medicine|2020|2.4k
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
|New England Journal of Medicine|1997|1.9k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k